LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis.

    Chai, Peiwei / Yu, Jie / Ge, Shengfang / Jia, Renbing / Fan, Xianqun

    Journal of hematology & oncology

    2020  Volume 13, Issue 1, Page(s) 43

    Abstract: ... remained to be elucidated in human cancers. Here, we analyzed genetic alteration, RNA expression, and DNA ... risk factor for COVID-19. In addition, the expression of angiotensin converting enzyme 2 (ACE2), the receptor ... of COVID-19 were people with malignancies. Moreover, cancer has been identified as an individual ...

    Abstract The novel coronavirus (2019-nCoV) is an emerging causative agent that was first described in late December 2019 and causes a severe respiratory infection in humans. Notably, many of affected patients of COVID-19 were people with malignancies. Moreover, cancer has been identified as an individual risk factor for COVID-19. In addition, the expression of angiotensin converting enzyme 2 (ACE2), the receptor of COVID-19, were aberrantly expressed in many tumors. However, a systematic analysis of ACE2 aberration remained to be elucidated in human cancers. Here, we analyzed genetic alteration, RNA expression, and DNA methylation of ACE2 across over 30 tumors. Notably, overexpression of ACE2 have been observed in including colon adenocarcinoma (COAD), kidney renal papillary cell carcinoma (KIRP), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), stomach adenocarcinoma (STAD), and lung adenocarcinoma (LUAD). In addition, hypo DNA methylation of ACE2 has also been identified in most of these ACE2 highly expressed tumors. Conclusively, our study for the first time curated both genetic and epigenetic variations of ACE2 in human malignancies. Notably, because our study is a bioinformatics assay, further functional and clinical validation is warranted.
    MeSH term(s) Angiotensin-Converting Enzyme 2 ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/enzymology ; Coronavirus Infections/etiology ; Coronavirus Infections/virology ; DNA Methylation ; DNA, Neoplasm/metabolism ; Humans ; Neoplasms/complications ; Neoplasms/enzymology ; Pandemics ; Peptidyl-Dipeptidase A/biosynthesis ; Peptidyl-Dipeptidase A/genetics ; Pneumonia, Viral/enzymology ; Pneumonia, Viral/etiology ; Pneumonia, Viral/virology ; RNA/biosynthesis ; Receptors, Coronavirus ; Receptors, Virus/biosynthesis ; Receptors, Virus/genetics ; SARS-CoV-2
    Chemical Substances DNA, Neoplasm ; Receptors, Coronavirus ; Receptors, Virus ; RNA (63231-63-0) ; Peptidyl-Dipeptidase A (EC 3.4.15.1) ; ACE2 protein, human (EC 3.4.17.23) ; Angiotensin-Converting Enzyme 2 (EC 3.4.17.23)
    Keywords covid19
    Language English
    Publishing date 2020-05-04
    Publishing country England
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 2429631-4
    ISSN 1756-8722 ; 1756-8722
    ISSN (online) 1756-8722
    ISSN 1756-8722
    DOI 10.1186/s13045-020-00883-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis

    Chai, Peiwei / Yu, Jie / Ge, Shengfang / Jia, Renbing / Fan, Xianqun

    J Hematol Oncol

    Abstract: ... remained to be elucidated in human cancers. Here, we analyzed genetic alteration, RNA expression, and DNA ... risk factor for COVID-19. In addition, the expression of angiotensin converting enzyme 2 (ACE2), the receptor ... of COVID-19 were people with malignancies. Moreover, cancer has been identified as an individual ...

    Abstract The novel coronavirus (2019-nCoV) is an emerging causative agent that was first described in late December 2019 and causes a severe respiratory infection in humans. Notably, many of affected patients of COVID-19 were people with malignancies. Moreover, cancer has been identified as an individual risk factor for COVID-19. In addition, the expression of angiotensin converting enzyme 2 (ACE2), the receptor of COVID-19, were aberrantly expressed in many tumors. However, a systematic analysis of ACE2 aberration remained to be elucidated in human cancers. Here, we analyzed genetic alteration, RNA expression, and DNA methylation of ACE2 across over 30 tumors. Notably, overexpression of ACE2 have been observed in including colon adenocarcinoma (COAD), kidney renal papillary cell carcinoma (KIRP), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), stomach adenocarcinoma (STAD), and lung adenocarcinoma (LUAD). In addition, hypo DNA methylation of ACE2 has also been identified in most of these ACE2 highly expressed tumors. Conclusively, our study for the first time curated both genetic and epigenetic variations of ACE2 in human malignancies. Notably, because our study is a bioinformatics assay, further functional and clinical validation is warranted.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #165275
    Database COVID19

    Kategorien

  3. Article ; Online: Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies

    Chai, Peiwei / Yu, Jie / Ge, Shengfang / Jia, Renbing / Fan, Xianqun

    Journal of Hematology & Oncology

    a pan-cancer analysis

    2020  Volume 13, Issue 1

    Keywords Cancer Research ; Oncology ; Molecular Biology ; Hematology ; covid19
    Language English
    Publisher Springer Science and Business Media LLC
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2429631-4
    ISSN 1756-8722
    ISSN 1756-8722
    DOI 10.1186/s13045-020-00883-5
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies

    Peiwei Chai / Jie Yu / Shengfang Ge / Renbing Jia / Xianqun Fan

    Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-

    a pan-cancer analysis

    2020  Volume 5

    Abstract: ... remained to be elucidated in human cancers. Here, we analyzed genetic alteration, RNA expression, and DNA ... risk factor for COVID-19. In addition, the expression of angiotensin converting enzyme 2 (ACE2), the receptor ... patients of COVID-19 were people with malignancies. Moreover, cancer has been identified as an individual ...

    Abstract Abstract The novel coronavirus (2019-nCoV) is an emerging causative agent that was first described in late December 2019 and causes a severe respiratory infection in humans. Notably, many of affected patients of COVID-19 were people with malignancies. Moreover, cancer has been identified as an individual risk factor for COVID-19. In addition, the expression of angiotensin converting enzyme 2 (ACE2), the receptor of COVID-19, were aberrantly expressed in many tumors. However, a systematic analysis of ACE2 aberration remained to be elucidated in human cancers. Here, we analyzed genetic alteration, RNA expression, and DNA methylation of ACE2 across over 30 tumors. Notably, overexpression of ACE2 have been observed in including colon adenocarcinoma (COAD), kidney renal papillary cell carcinoma (KIRP), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), stomach adenocarcinoma (STAD), and lung adenocarcinoma (LUAD). In addition, hypo DNA methylation of ACE2 has also been identified in most of these ACE2 highly expressed tumors. Conclusively, our study for the first time curated both genetic and epigenetic variations of ACE2 in human malignancies. Notably, because our study is a bioinformatics assay, further functional and clinical validation is warranted.
    Keywords COVID-19 ; ACE2 ; Expression ; Diseases of the blood and blood-forming organs ; RC633-647.5 ; Neoplasms. Tumors. Oncology. Including cancer and carcinogens ; RC254-282 ; covid19
    Language English
    Publishing date 2020-05-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Book ; Online: Faculty Opinions recommendation of Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies

    Gossell-Williams, Maxine

    Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

    a pan-cancer analysis.

    2020  

    Keywords covid19
    Publisher Faculty Opinions Ltd
    Publishing country uk
    Document type Book ; Online
    DOI 10.3410/f.737902721.793574453
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top